Increased Understanding of CLL Tumor Biology Unlocks Targeted CAR T-Cell Approaches

Jan Joseph Melenhorst, PhD, emphasizes how research investigating chronic lymphocytic leukemia biology may result in more targeted CAR T-cell products.

Related Keywords

Cleveland ,Ohio ,United States ,Jan Joseph Melenhorst ,Adrian Wiestner ,Jamesn Kochenderfer ,Michel Sadelain ,Lyell Immunopharma ,National Cancer Institute ,International Workshop ,Oncology Program At Case Comprehensive Cancer Center ,University Of Pennsylvania ,Hospital Of The University Pennsylvania ,Cell Therapy ,Precision Immuno Oncology ,Cleveland Clinic ,Immune Oncology Program ,Case Comprehensive Cancer Center ,News ,Cll ,Cart Cell ,